TKD fundamentals
An in-depth look to Takeda Pharmaceutical Co. Ltd. operating, investing, and financing activities
TKD free cash flow for Q4 23 is 1.4 B EUR. For 2023, TKD free cash flow was 2.85 B EUR and operating cash flow was 3.92 B EUR.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM